A growing number of organizations are moving beyond compliance to foster diversity, equity and inclusion in their workplaces. According to research, companies that have embraced a DEI strategy improved their bottom line with a 53 per cent return on equity, a 42 per cent return on sales, in addition to being 70 per cent more […]
One in five Canadians will experience a mental illness in their lifetime and by age 40 about 50 per cent of the population will have or have had one. Mental illness includes conditions such as depression, schizophrenia or bipolar disorder, which “can really affect the ability of an individual to function,” said Nida Mian, senior […]
In 2020, members of the Canadian Life and Health Insurance Association spent $650 million on drugs for rare diseases for more than 13,000 patients. Rare diseases affect one in 12 Canadians and between 6,000 and 8,000 rare diseases are known globally. In addition, roughly 80 per cent of these diseases occur in children and only […]
The World Health Organization has designated diabetes as the only non-viral epidemic and diabetes drugs continue to be ranked as the second highest cost category for private drug plans, said Lisa Maks, clinical nurse specialist at Juravinski Hospital and St. Peter’s Hospital sites, during a session at Benefits Canada’s 2021 Mental Health Summit. Eight per cent […]
Pharmacogenetic testing has become a popular addition to employee benefits packages, primarily because of its ability to inform personalized drug treatment, especially in mental health where it can be challenging to find an appropriate treatment and dosage that’s effective without causing side-effects. Many patients end up trying multiple medications and dosages without achieving improved outcomes, […]
Approximately two in five Canadians live with a mental-health disorder and about eight million are struggling with non-prescriptive addiction. Medically managed intensive outpatient programming, or MMIOP, provides rapid access to treatment, resolution of symptoms and rapid return to work, said Dr. Rob Tanguay, vice-president and chief medical officer at the Newly Institute, during a session […]
Mental health is a major pandemic in and of itself, with surveys showing a 300 per cent increase in people reporting symptoms of anxiety and depression during the coronavirus pandemic. Despite the availability of hundreds of drug treatments, rates of mental illness continue to increase and “there hasn’t been any pharmacotherapy innovation for mental illness,” […]
The proposed amendments to the patented medicines regulations by the Patented Medicine Prices Review Board could have a big impact on both the group insurance and pharmaceutical industry. “The CLHIA is very supportive of PMPRB adjustments that may be coming,” said Joan Weir, director of health and disability policy at the Canadian Life and Health […]
Innovative technology to monitor glucose levels for patients with diabetes offers improved health outcomes, reduced absenteeism and improved productivity, said Rick Siemens, certified diabetes educator pharmacist, during a webinar in June hosted by Benefits Canada and sponsored by Dexcom. The roles of pharmacists in Canada are evolving. Siemens said he spends most of his time […]
Approximately 10 per cent of Canadians live with diabetes and one in 300 children live with Type 1 diabetes, according to Dr. Angelo Simone, a paediatric endocrinologist at Trillium Health Partners, during a webinar hosted by Benefits Canada and sponsored by Abbott in April. As a parent caring for two children living with Type 1 […]